Patent · US Active

Antibodies to IL-17A

US7846443B2 · kind B2 · utility

15Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2007
Grant dateDec 7, 2010
Priority date—
Expiry dateNov 8, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Engineered antibodies to human IL-17A are provided, as well as uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.